Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-018923
Filing Date
2025-02-12
Accepted
2025-02-12 16:32:59
Documents
1
Period of Report
2025-02-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5737
  Complete submission text file 0000950170-25-018923.txt   7180
Mailing Address INDEVUS PHARMACEUTICALS, INC. 99 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Tucker John H (Reporting) CIK: 0001303480 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38293 | Film No.: 25615365

Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Issuer) CIK: 0001604950 (see all company filings)

EIN.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)